Table 5_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx حسب Baodong Wang (3359171)

"…Finally, it is forecasted that the smoking-related LBP burden will decrease from 2022 to 2036.</p>Conclusion<p>From 1990 to 2021, the global ASDR of LBP attributable to smoking decreased, and this downward trend is expected to persist. …"

Table 1_Inflammation and nutritional status in relation to mortality risk from cardio-cerebrovascular events: evidence from NHANES.docx حسب Chengzhi Hou (20419865)

"…To the right, the risk might increase by 0.2%, although the change was not statistically significant. Subgroup analyses and sensitivity analyses showed that the association between ALI and risk of mortality remained stable in most MACCE survivor populations.…"

Data Sheet 2_Cervical cancer burden and attributable risk factors across different age and regions from 1990 to 2021 and future burden prediction: results from the global burden of... حسب Lu-yao Cheng (20687651)

"…</p>Results<p>Globally, the number of CC cases has increased from 409,548.49 cases in 1990 to 667,426.40 cases in 2021. However, the ASIR decreased from 18.11 to 15.32 per 100,000, with the greatest ASIR decrease in high SDI regions (estimated annual percentage change: -1.41). …"

Table 3_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx حسب Baodong Wang (3359171)

"…Finally, it is forecasted that the smoking-related LBP burden will decrease from 2022 to 2036.</p>Conclusion<p>From 1990 to 2021, the global ASDR of LBP attributable to smoking decreased, and this downward trend is expected to persist. …"

Data Sheet 1_Cervical cancer burden and attributable risk factors across different age and regions from 1990 to 2021 and future burden prediction: results from the global burden of... حسب Lu-yao Cheng (20687651)

"…</p>Results<p>Globally, the number of CC cases has increased from 409,548.49 cases in 1990 to 667,426.40 cases in 2021. However, the ASIR decreased from 18.11 to 15.32 per 100,000, with the greatest ASIR decrease in high SDI regions (estimated annual percentage change: -1.41). …"

Image 1_Global, regional, and national burden of nutritional deficiencies spanning from 1990 to 2021, with a focus on the impacts observed during the COVID-19 pandemic.tif حسب Yue-Yang Zhang (14258160)

"…</p>Conclusions<p>Despite a decline in the global burden of nutritional deficiencies over time, significant disparities related to gender, region, and age persist. …"

Image 1_Inflammation and nutritional status in relation to mortality risk from cardio-cerebrovascular events: evidence from NHANES.tif حسب Chengzhi Hou (20419865)

"…To the right, the risk might increase by 0.2%, although the change was not statistically significant. Subgroup analyses and sensitivity analyses showed that the association between ALI and risk of mortality remained stable in most MACCE survivor populations.…"

Data Sheet 2_Toxocariasis in children: seroprevalence after 15 years in a major city in Brazil.docx حسب Viviane dos Santos Vaccaro Lima (22644209)

"…</p>Discussion<p>Toxocara seroprevalence in children living in an urban area did not significantly change over the 15 years since the previous serosurvey was conducted. …"

Table 7_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx حسب Baodong Wang (3359171)

"…Finally, it is forecasted that the smoking-related LBP burden will decrease from 2022 to 2036.</p>Conclusion<p>From 1990 to 2021, the global ASDR of LBP attributable to smoking decreased, and this downward trend is expected to persist. …"

Table 2_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xls حسب Baodong Wang (3359171)

"…Finally, it is forecasted that the smoking-related LBP burden will decrease from 2022 to 2036.</p>Conclusion<p>From 1990 to 2021, the global ASDR of LBP attributable to smoking decreased, and this downward trend is expected to persist. …"

Data Sheet 1_Toxocariasis in children: seroprevalence after 15 years in a major city in Brazil.pdf حسب Viviane dos Santos Vaccaro Lima (22644209)

"…</p>Discussion<p>Toxocara seroprevalence in children living in an urban area did not significantly change over the 15 years since the previous serosurvey was conducted. …"

Table 1_Cervical cancer burden and attributable risk factors across different age and regions from 1990 to 2021 and future burden prediction: results from the global burden of dise... حسب Lu-yao Cheng (20687651)

"…</p>Results<p>Globally, the number of CC cases has increased from 409,548.49 cases in 1990 to 667,426.40 cases in 2021. However, the ASIR decreased from 18.11 to 15.32 per 100,000, with the greatest ASIR decrease in high SDI regions (estimated annual percentage change: -1.41). …"

Image 1_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.tif حسب Baodong Wang (3359171)

"…Finally, it is forecasted that the smoking-related LBP burden will decrease from 2022 to 2036.</p>Conclusion<p>From 1990 to 2021, the global ASDR of LBP attributable to smoking decreased, and this downward trend is expected to persist. …"

Table 1_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx حسب Baodong Wang (3359171)

"…Finally, it is forecasted that the smoking-related LBP burden will decrease from 2022 to 2036.</p>Conclusion<p>From 1990 to 2021, the global ASDR of LBP attributable to smoking decreased, and this downward trend is expected to persist. …"

Table 6_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.xlsx حسب Xinyi Lyu (14756739)

"…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …"

Table 2_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.xlsx حسب Xinyi Lyu (14756739)

"…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …"

Table 7_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.xlsx حسب Xinyi Lyu (14756739)

"…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …"

Image 1_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.tif حسب Xinyi Lyu (14756739)

"…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …"

Image 2_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.tif حسب Xinyi Lyu (14756739)

"…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …"

Table 1_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.xlsx حسب Xinyi Lyu (14756739)

"…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …"